Gomez Alvaro, Parodis Ioannis, Saleh Muna, Simard Julia F, Sjöwall Christopher, Arkema Elizabeth V
Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden
Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Lupus Sci Med. 2025 Feb 26;12(1):e001403. doi: 10.1136/lupus-2024-001403.
To develop a Register-Based Organ Damage Index (RBODI) in SLE, and evaluate its accuracy in estimating Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index (SDI) scores. Additionally, to describe organ damage accrual and associations with mortality in a Swedish population-based nationwide cohort.
SDI items were translated into diagnosis, treatment and procedural codes retrieved from Swedish health registers. RBODI was calculated using the same rules as the SDI and its accuracy was evaluated using SDI data from the cohort as the gold standard. Among newly diagnosed patients with SLE from Sweden (2005-2021), we estimated 5-year risks of organ damage, and adjusted HRs of first RBODI-based organ damage accrual associated with patient characteristics. Lastly, we estimated the association between RBODI-based organ damage within 5 years of diagnosis and mortality.
The evaluation cohort included 271 prevalent cases (65.3% developed organ damage). RBODI had a positive predictive value of 90%, sensitivity 80% and specificity 83%. Among 4441 newly diagnosed patients with SLE, 40% developed organ damage within 5 years. Males had a 30% higher risk of developing damage compared with females (HR 1.3) and older individuals (>45 years old compared with younger) had more than threefold higher risk (HR 3.3). Early development of organ damage was associated with a 2.1-fold higher risk of mortality.
Our novel RBODI accurately estimates SDI scores and describes long-term trends in damage accrual in the largest cohort of incident SLE to date. The strong association between early damage accrual and mortality highlights the need for efficient prevention strategies.
开发一种基于登记册的系统性红斑狼疮器官损伤指数(RBODI),并评估其在估计系统性红斑狼疮国际协作临床中心/美国风湿病学会(SLICC/ACR)损伤指数(SDI)评分方面的准确性。此外,描述瑞典全国性人群队列中器官损伤的累积情况及其与死亡率的关联。
将SDI项目转化为从瑞典健康登记册中检索到的诊断、治疗和程序代码。使用与SDI相同的规则计算RBODI,并以该队列的SDI数据作为金标准评估其准确性。在瑞典新诊断的系统性红斑狼疮患者(2005 - 2021年)中,我们估计了器官损伤的5年风险,以及与患者特征相关的首次基于RBODI的器官损伤累积的调整后风险比。最后,我们估计了诊断后5年内基于RBODI的器官损伤与死亡率之间的关联。
评估队列包括271例现患病例(65.3%发生了器官损伤)。RBODI的阳性预测值为90%,敏感性为80%,特异性为83%。在4441例新诊断的系统性红斑狼疮患者中,40%在5年内发生了器官损伤。男性发生损伤的风险比女性高30%(风险比1.3),年龄较大者(>45岁与较年轻者相比)的风险高出三倍多(风险比3.3)。器官损伤的早期发生与死亡风险高出2.1倍相关。
我们新的RBODI准确估计了SDI评分,并描述了迄今为止最大的系统性红斑狼疮发病队列中损伤累积的长期趋势。早期损伤累积与死亡率之间的强关联凸显了有效预防策略必要性。